It’s well established that secondhand smoke from cigarettes is a risk to anyone who suffers from asthma. New research being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting shows it’s possible for both children and adults with uncontrolled asthma to find their symptoms worsening due to cannabis allergy and exposure to marijuana smoke.
Asthma is a complex disease, and it can be a challenge to keep up with your child’s medications and treatments. New research being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting shows children of caregivers with poor asthma knowledge were four times more likely to have a prolonged hospital stay. A “prolonged” stay was defined as more than two days.
If the thought of sucking your baby’s pacifier to clean it and then popping it in your baby’s mouth grosses you out, think again. New research being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests a link between parental sucking on a pacifier and a lower allergic response among young children.
Asthma is a complex condition. People can have different levels of asthma, triggers and treatments. Whether you’ve just been diagnosed or have had asthma for some time, you may need help making sense of it all. The Asthma and Allergy Foundation of America (AAFA) has created the ASTHMA Care for Adults program. This program covers a full range of topics someone with asthma needs to know.
The asthma & allergy friendly® Certification Program, administered by the Asthma and Allergy Foundation of America (AAFA) in partnership with Allergy Standards Limited (ASL), is an independent program created to scientifically test and identify consumer products that support the need for people with asthma and allergy to make their home environment healthier.
The Asthma and Allergy Foundation of America (AAFA) announces the election of Dr. Richard K. Murray, MD, FACP, as the new board chair. Dr. Murray has served as a leader on AAFA’s board of directors since 2016.
In the summer of 2017, Alexis Fetterman and her parents had an unexpected introduction to asthma and allergies . Alexis was 2 years old and got sick with a respiratory virus. After a visit to the emergency room, she was admitted to the hospital and flown to a nearby children’s hospital. After a few days in the hospital, Alexis was diagnosed with asthma. “The hospital stay was a really traumatic experience. Since then, I’ve immersed myself in learning about asthma and allergies. I want to...
People with asthma have more treatment choices than ever before, and the FDA recently announced approval for the readmittance of Primatene Mist – an over-the-counter (OTC) epinephrine inhaler. The Asthma and Allergy Foundation of America (AAFA) cautions patients to not stop their current asthma treatment nor start taking this OTC option without talking to their health care provider first.
The Asthma and Allergy Foundation of America (AAFA) with support provided by the U.S. Centers for Disease Control and Prevention (CDC) has created and launched the Asthma Symptoms, Treatment, Health Management and Activities™ (ASTHMA) Care for Adults program to help patients manage asthma and improve their health. The program covers a full range of topics someone with asthma needs to know.
Kadesh Incorporation Issues Voluntary Nationwide Recall of Puriton Eye Relief Drops Due to Non-Sterile Production Conditions For Immediate Release November 7, 2018 Contact Consumers Recall Department firstname.lastname@example.org Announcement Kadesh, Inc. of Garden Grove, CA is voluntarily recalling all lots of Puriton Eye Relief Drops, 0.5 oz. (15ml) bottle, UPC 7 36972 1679 0, to the consumer level. During a recent FDA inspection, investigators observed that ophthalmic drugs, which are required to be...
FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may block access to the auto-injector and prevent the ability to easily access the product.
The Asthma and Allergy Foundation of America (AAFA) in partnership with Allergy Standards Limited (ASL) announced findings from a new market research survey aimed at better understanding patient and consumer awareness, perceptions and values of certified products and the asthma & allergy friendly® Certification Program, as well as buyer behaviors and demands.
There are a variety of treatments for eczema, including creams and ointments. But your doctor may also recommend moisturizing methods, like "soak and seal" and "wet wrapping." These therapies can help your topical medicines be more effective. Everyone's eczema is different, and there are many ways you can manage flare-ups. Talk to your doctor about therapies that may work best for you.
The Asthma and Allergy Foundation of America (AAFA), the premiere nonprofit representing patients with asthma and allergies, applauds the recent request for information and statement from the Food and Drug Administration (FDA) demonstrating its commitment to explore the classification of sesame as a major allergen.
Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.